Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$455K Buy
16,486
+1,124
+7% +$24.8K ﹤0.01% 1147
2026
Q1
$225K Buy
15,362
+2,503
+19% +$36.7K ﹤0.01% 1422
2025
Q4
$163K Buy
12,859
+41
+0.3% +$605 ﹤0.01% 1418
2025
Q3
$197K Buy
12,818
+92
+0.7% +$1.48K ﹤0.01% 1367
2025
Q2
$200K Buy
12,726
+556
+5% +$8.43K ﹤0.01% 1333
2025
Q1
$232K Buy
12,170
+662
+6% +$14.5K ﹤0.01% 1211
2024
Q4
$274K Buy
11,508
+2,631
+30% +$73.4K ﹤0.01% 1160
2024
Q3
$249K Buy
+8,877
New +$251K ﹤0.01% 1153
2023
Q1
Sell
-16,033
Closed -$276K 1253
2022
Q4
$276K Buy
+16,033
New +$284K ﹤0.01% 1052

Other funds holding RXO

Xponance's RXO Position: Q2 2026 in Review

Xponance increased its RXO (RXO) stake by 7.3% in Q2 2026, buying an estimated $24.8K and bringing the position to 16,486 shares worth $455K. The position accounts for ﹤0.01% of the portfolio, ranked #1147.

Xponance first reported a position in RXO in Q4 2022 and has held it in 9 quarters since. 303 funds tracked by Wall St. Rank hold RXO as of Q2 2026.

  • Xponance held 16,486 shares of RXO worth $455K as of Q2 2026.
  • Xponance bought 1,124 RXO shares in Q2 2026, an estimated $24.8K.
  • RXO made up ﹤0.01% of Xponance's portfolio in Q2 2026, its #1147 holding.
  • Xponance first reported a position in RXO in Q4 2022 and has held it in 9 quarters since.
  • 303 funds tracked by Wall St. Rank held RXO as of Q2 2026.

Based on Xponance's 13F filing for Q2 2026, filed 10 Aug 2026.